Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple System Atrophy - Parkinsonian Subtype (MSA-P)”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableUnknownNCT06890390
What this trial is testing

TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Not applicableStudy completedNCT02035761
What this trial is testing

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy - Cerebellar Subtype (MSA-C)
University of Michigan 23
Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Not applicableUnknownNCT06890377
What this trial is testing

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT07825402
What this trial is testing

A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)

Who this might be right for
Multiple System Atrophy, Parkinson Variant
Ono Pharmaceutical Co., Ltd. 486
Testing effectiveness (Phase 2)Study completedNCT00977665
What this trial is testing

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Who this might be right for
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D, Inc. 174
Not applicableLooking for participantsNCT06647641
What this trial is testing

The CurePSP Genetics Program

Who this might be right for
PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+17 more
Massachusetts General Hospital 1,000
Very early researchLooking for participantsNCT06765733
What this trial is testing

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy, MSA
Beijing Tiantan Hospital 20
Early research (Phase 1)Looking for participantsNCT07289477
What this trial is testing

A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd. 9